Mint Tower Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Mint Tower Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,072	Closed	-$750K	–	466
2021 Q4	$750K	Buy	+8,072	New	+$532K	0.1%	197

Mint Tower Capital Management's ARNA Position: Q1 2022 in Review

Mint Tower Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 8,072 shares — an estimated $750K sold.

Mint Tower Capital Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $750K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Mint Tower Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Mint Tower Capital Management sold 8,072 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $750K.
Mint Tower Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Mint Tower Capital Management's Arena Pharmaceuticals Inc position peaked at $750K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Mint Tower Capital Management's 13F filing for Q1 2022, filed 29 Apr 2022.